DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Celgene

News

Bristol-Myers Squibb Takes Celgene for $74 Billion

07.01.2019 - In the first major pharma deal of the year, Bristol-Myers Squibb (BMS) is to acquire biotech giant Celgene for $74 billion. The cash-and-stock transaction values the US biotech at...

Strategy & Management

Along the Acquisition Trail

17.04.2018 - For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...

News

Celgene COO Scott Smith Steps Down

06.04.2018 - In line with what it said were plans to modify its executive team structure “to enhance leadership focus on building the company for continued long-term success,” Celgene said its...

News

Celgene Settles Whistleblower Suit for $280 Million

27.07.2017 - US pharmaceutical company Celgene has agreed to pay $280 million to settle a whistleblower lawsuit accusing it of fraud for promoting a thalidomide-based drug pair re-purposed to...

News

Celgene to Buy into China’s BeiGene

13.07.2017 - US biopharmaceutical company Celgene has agreed to buy a stake in China’s BeiGene and help to develop and commercialize that company’s investigational treatment for tumor cancers...

News

FDA Stops US Merck Keytruda Trials

12.07.2017 - The US Food and Drug Administration (FDA) has placed a clinical hold on three phase 3 multiple myeloma studies testing US drugmaker Merck’s Keytruda (pembrolizumab) in combination...

News

US Merck Halts Trial Enrollment After Deaths

14.06.2017 - US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...

News

US Drugmakers Urge Tax Code Reform

24.02.2017 - In a letter to the leadership of the US Congress, 16 CEOs of major American companies, including Pfizer’s Ian Read, Eli Lilly’s David Ricks, Merck & Co’s Ken Frazier and Celgene’s...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.